Home
About Us
Management
Membership
Events
Sponsors
Affiliates
Chapters
Contact Us
Subscribe
Job Postings
Speaker Presentations
Annual Conference 2010
Annual Conference 2011
Annual Conference 2012
Annual Conference 2013
Annual Conference 2014
Annual Conference 2015
e-News Letter
   
 

Annual Conference 2013 »
 

The EPPIC 2013 Annual Conference

 

Date: Sunday, January 6th 2013, 8:00AM - 7:30PM

 

Venue: Westin San Francisco Airport, 1 Old Bayshore Hwy, Millbrae, CA 94030.

 

New Frontiers in Health Care Sciences

 
EPPIC 2013 Conference Agenda
8.00 - 8.30 amRegistration, Breakfast And Networking
8.30 - 8.35 amWelcome: Ramani A. Aiyer, EPPIC President, Principal, Shasta BioVentures
8.35 - 9.30 amPlenary Session: "SYNTHETIC BIOLOGY"
 

Keynote Speaker: Carlos Olguin, Head, Nanotechnology And Programmable Matter Group, Autodesk
Moderator: John Cumbers, Head, Synthetic Biology & Resource Utilization In Space, Nasa Ames

9.30 - 10.30 amPanel1: Personalized Medicine
 

Moderator: Sara Kenkare-Mitra, VP Development Sciences, Genentech , Inc.
Brian Naughton, Founding Scientist, 23andMe
Deborah Kilkpatrick, Chief Commercial Officer, CardioDx
Eric Sasso, VP, Medical & Scientific Affairs, Crescendo Bioscience

 

Personalized Medicine has been broadly used term to address variety of different perspectives in healthcare. Our panel provides an opportunity to look at three different companies who have taken very different approaches to provide new solutions to patients while building new business models. Knowing specific genetic risk factors, and exploiting the knowledge of these risk factors to create individualized treatment plans has been only a dream until recently. Our panel provides a real world view of the opportunities and challenges in offering new solutions to patients while also navigating through the complex world of creating awareness among healthcare providers, dealing with the FDA and aligning with payers. Our panelists will discuss their experiences in the area of personalized medicine as it pertains to areas like rheumatology, cardiology and the emerging areas of personal genomics.

10.30 - 10.45 amCoffee and Networking Break
10.45 - 12 NoonPanel 2: Repurposing Of Drugs
 

Keynote Address: Ken Phelps, CEO, Camargo Pharmaceutical Services
Moderator: Mahendra Shah, Venture Partner, Vivo Ventures
Ken Phelps, CEO, Camargo Pharmaceutical Services
Jaisim Shah, Strategic Business Consultant
Warren Cooper, President, Coalescence Inc.

 

New drug development is a very risky business that costs over a $1 Billion and takes more than 10 years to get FDA approval. Once the new drug is approved, there is no guarantee that it will be commercially successful because of restrictions placed by payers or unanticipated side effects. Repurposing of drugs has become one of the creative approaches to bring new drugs to market and to create value for the companies and investors. Entrepreneurs and investors are looking at currently approved drugs, and trying to find new indications for them and / or improve them by developing new formulations to reduce side effects and increase compliance. While these ideas sound simple, they require a great expertise in understanding the regulatory pathways, the market opportunities and to show real value for patients and healthcare providers. Our panelists have done this multiple times, and they bring their perspectives in this interactive panel from the trenches.

12.00 - 1.00 pmLunch Break
1.00 - 2.00 pmPanel 3: Speed Pitch
 

Moderator: Shalabh Gupta, President & CEO, BioCycive, Inc.
VC Panel: Ash Khanna, Principal, SV Life Sciences
Rishi Gupta, Principal, OrbiMed Advisor
Geeta Vemuri, Senior Managing Director, Baxter Ventures
Mudit Jain, Partner, Synergy Life Sciences Partners

 

The idea is to get multiple entrepreneurs and early stage companies in life‐sciences give a 5-minute pitch about their idea, technology, company. They will present to the entire audience, obtain quick feedback from the distinguished VC panel above, and get exposure to various potential collaborators, partners, and investors. Selected presentations will get highlighted on the EPPIC website and other promotional material. The best presenter will be offered a 30 minute one on one session with a venture capitalist, an IP partner, a corporate attorney and a specialist from a CRO.

2.00 - 3.15 pmPanel 4: Accent On Youth
 

Moderator: Kenneth Hess, Founder-President, Science Buddies
Blake Marggraff, Winner, Intel International Science And Engineering Fair (Isef), May 2011
Madeline Sides, Winner, Intel International Science And Engineering Fair (Isef), May 2010
Kettner Griswold, Jr., Thiel Fellow (Thiel Foundation) And President, Cto And Co-Founder, Evolutionary Solutions Inc.
Divya Nag, Founder At Startx Med; Co-Founder At Stem Cell Theranostics

 

This Is An Eppic Annual Conference First : A Youth Panel To Showcase Outstanding Research By Budding Scientists. Students In High Schools And In Early College Years Will Be Given An Opportunity To Present Their Original Research And Innovations. The Purpose Of This Forum Is To Inspire Their Excellence And Expand Networking Opportunities With Peers With Similar Interests.

3.15 - 4.15pmSpeed Networking
 

An Opportunity To Meet Conference Attendees With Three-Minute Quick Introductions With Groups Of Three Attendees, And Also In A Group Setting. Make Sure You Bring Plenty Of Business Cards!

4.15 - 5.15pmPanel 5: Technology Innovations That Shorten Therapeutic Product Development Life-Cycles
 

Moderators: Mohan Srinivasan, Director, Bristol-Myers Squibb / Medarex
Pradeep Fernandes, Co-Founder & President, Cellworks Group Inc.
Nikesh Kotecha, Ceo & Founder, Cytobank, Inc.
Scott Turner, Executive Vp, Research & Development, Kinemed
Parag Mallick, Assistant Professor, Canary Center For Cancer Early Detection, Stanford University
Chunlin Wang, Senior Research Scientist & Director Of Informatics, Stanford Genome Technology Center

 

Product Life-Cycles In Technology And Drug-Development Sectors Are Very Different. For Each New Therapeutic, It Ranges Between 9 To 15 Years, Costing At Least $500m, While The Timelines Are Much Shorter In The Technology Sector With Varied Costs. Shortening The Timelines While Improving The Overall Chances Of Success Are The Two Key Approaches For Optimization Of New Therapeutic Life-Cycle. In This Panel We Will Discuss How Various Technology Adaptations Are Made In Drug-Development Sector To Compress This Life-Cycle While Boosting Success Rates.

5.15 - 5.30 pmClosing Remarks: Geetha Rao (Conference Co-Chair) CEO, Springborne Life Sciences & Vice President, Corporate Development, Triple Ring Technologies
5.30 - 7.00 pmEvening Reception: Cocktails And Light Refreshments


Registration: Click here to register.

Early Bird Registration: $100 (ends on Dec 28th, 11.55 pm)

Advance Registration: $125 (Dec 29th - Jan 5th, 11.55 pm)

On-site Registration: $150 (Jan 6th 7.30 am - 1 pm)

Student/Postdoc registration: $50 (ends by Dec 28th, only first 25 will be allowed). A valid ID must be shown. Otherwise, they will be considered as a regular attendee.

Registration fee is waived for Charter Members (please write to "eppicglobal@gmail.com" for charter membership benefits), if you are interested in becoming a Charter Member for the 2013 calendar year.

Attendees who plan to register through check option must send the check payable to "EPPIC GLOBAL" and mail the check to EPPIC mailing address (EPPIC GLOBAL NETWORK, PMB# 402, 4546 El Camino Real, Suite B-10, Los Altos, CA 94022-1069) no later than Dec 31st, 2012.

Checks received after Dec 31st considered as on-site registration and you will have to pay additional $50 ($150 instead of $100).

No refunds on registration fee. But transferring the registration fee to another attendee can be considered by only prior written request to "eppicglobal@gmail.com".

 
To register for this event, click here
 
Copyrights © 2016, EPPIC Global. All Rights Reserved